TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Journal of Nuclear Medicine and Molecular Imaging

• Publication date

  2017-08-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00259-017-3799-9PMID 28821920
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 18F-fluorothymidine PET imaging in gliomas: an update

  2017cited by this paper
• Quantification of the new TSPO ligand [F-18]GE-180 in patients with multiple sclerosis - initial results

  2017cited by this paper
• Flutriciclamide (18F-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein

  2016cited by this paper
• Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study

  2016cited by this paper
• Usefulness of PET Imaging to Guide Treatment Options in Gliomas

  2016cited by this paper
• ESTRO-ACROP guideline "target delineation of glioblastomas".

  2016cited by this paper
• Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain

  2016cited by this paper
• Utilization of PET imaging in differential diagnostics between a tumefactive multiple sclerosis lesion and low-grade glioma.

  2016cited by this paper
• TSPO expression in brain tumours: is TSPO a target for brain tumour imaging?

  2016cited by this paper
• Suspected recurrence of brain metastases after focused high dose radiotherapy: can [18F]FET- PET overcome diagnostic uncertainties?

  2016cited by this paper
• Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

  2016cited by this paper
• TSPO Imaging in Glioblastoma Multiforme: A Direct Comparison Between 123I-CLINDE SPECT, 18F-FET PET, and Gadolinium-Enhanced MR Imaging

  2015cited by this paper
• Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary Study

  2015cited by this paper
• Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients.

  2015cited by this paper
• From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?

  2015cited by this paper
• Early static 18F-FET-PET scans have a higher accuracy for glioma grading than the standard 20–40 min scans

  2015cited by this paper
• 18F-GE-180: a novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke

  2015cited by this paper
• Prognostic Significance of Dynamic 18F-FET PET in Newly Diagnosed Astrocytic High-Grade Glioma

  2015cited by this paper
• The 18-kDa Mitochondrial Translocator Protein in Human Gliomas: An 11C-(R)PK11195 PET Imaging and Neuropathology Study

  2015influential reference
• Detection of Microglial Activation in an Acute Model of Neuroinflammation Using PET and Radiotracers 11C-(R)-PK11195 and 18F-GE-180

  2014cited by this paper
• Preclinical Imaging Evaluation of Novel TSPO-PET Ligand 2-(5,7-Diethyl-2-(4-(2-[18F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([18F]VUIIS1008) in Glioma

  2014cited by this paper
• EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma.

  2014cited by this paper
• A randomized trial of bevacizumab for newly diagnosed glioblastoma.

  2014cited by this paper
• Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.

  2014cited by this paper
• The Translocator Protein Radioligand 18F-DPA-714 Monitors Antitumor Effect of Erufosine in a Rat 9L Intracranial Glioma Model

  2013cited by this paper
• Diagnostic Performance of 18F-FET PET in Newly Diagnosed Cerebral Lesions Suggestive of Glioma

  2013cited by this paper
• [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.

  2013cited by this paper
• [11C]-(R)PK11195 tracer kinetics in the brain of glioma patients and a comparison of two referencing approaches

  2013cited by this paper
• Quantitative Preclinical Imaging of TSPO Expression in Glioma Using N,N-Diethyl-2-(2-(4-(2-18F-Fluoroethoxy)Phenyl)-5,7-Dimethylpyrazolo[1,5-a]Pyrimidin-3-yl)Acetamide

  2012cited by this paper
• [¹⁸F]GE-180: a novel fluorine-18 labelled PET tracer for imaging Translocator protein 18 kDa (TSPO).

  2012cited by this paper
• The translocator protein ligand [18F]DPA-714 images glioma and activated microglia in vivo

  2012cited by this paper
• Imaging brain microglial activation using positron emission tomography and translocator protein-specific radioligands.

  2011cited by this paper
• Quantitative, Preclinical PET of Translocator Protein Expression in Glioma Using 18F-N-Fluoroacetyl-N-(2,5-Dimethoxybenzyl)-2-Phenoxyaniline

  2011cited by this paper
• Protein kinase C epsilon regulation of translocator protein (18 kDa) Tspo gene expression is mediated through a MAPK pathway targeting STAT3 and c-Jun transcription factors.

  2010cited by this paper
• Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of Neuroinflammation

  2010cited by this paper
• Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states.

  2010cited by this paper
• Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

  2009cited by this paper
• The positive predictive value of O-(2-[18F]fluoroethyl)-l-tyrosine (FET) PET in the diagnosis of a glioma recurrence after multimodal treatment

  2008cited by this paper
• The lack of expression of the peripheral benzodiazepine receptor characterises microglial response in anaplastic astrocytomas

  2007cited by this paper
• Immunohistochemical expression of peripheral benzodiazepine receptors in human astrocytomas and its correlation with grade of malignancy, proliferation, apoptosis and survival

  2006cited by this paper
• O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas.

  2005cited by this paper
• Value of O-(2-[18F]fluoroethyl)-l-tyrosine PET for the diagnosis of recurrent glioma

  2004cited by this paper
• Flow cytometric characterization of tumor-associated macrophages in experimental gliomas.

  2000cited by this paper
• PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report.

  1991cited by this paper
• Increased density of peripheral benzodiazepine-binding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovaries.

  1990cited by this paper
• Increase in peripheral benzodiazepine binding sites in colonic adenocarcinoma.

  1990cited by this paper
• PET Imaging of human gliomas with ligands for the peripheral benzodiazepine binding site

  1989cited by this paper

• Translocator protein (TSPO) in glioma: implications for diagnosis, disease progression monitoring, and targeted therapies

  2025cites this paper
• Spatio-Temporal Dynamics of M1 and M2 Macrophages in a Multiphase Model of Tumor Growth

  2025cites this paper
• Magnetic susceptibility properties of tumor-associated cells imaged by MRI reveal glioblastoma infiltration in the edema region

  2025cites this paper
• PET imaging pitfall in recurrent oligodendroglioma with drug-resistant epilepsy: illustrative case

  2025cites this paper
• Emerging PET-radiotracers in cardiovascular, neuro-inflammation, lung and rheumatological diseases: a narrative review

  2025cites this paper
• Nuclear Medicine Imaging Techniques in Glioblastomas

  2024cites this paper
• Clinical Theranostics in Recurrent Gliomas: A Review

  2024cites this paper
• Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET

  2024cites this paper
• The development status of PET radiotracers for evaluating neuroinflammation

  2024influential citation
• The Traumatic Inoculation Process Affects TSPO Radioligand Uptake in Experimental Orthotopic Glioblastoma

  2024cites this paper
• Myeloid cell-specific loss of NPC1 in mice recapitulates microgliosis and neurodegeneration in patients with Niemann-Pick type C disease.

  2024cites this paper
• Imaging tumor and ascites-associated macrophages in a mouse model of metastatic ovarian cancer

  2024cites this paper
• Emerging TSPO-PET Radiotracers for Imaging Neuroinflammation: A Critical Analysis.

  2024cites this paper
• Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer’s disease

  2024cites this paper
• Machine learning-based approach reveals essential features for simplified TSPO PET quantification in ischemic stroke patients

  2023cites this paper
• Microglial Imaging in Alzheimer’s Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study

  2023cites this paper
• Structural Insights into the Binding and Degradation Mechanisms of Protoporphyrin IX by the Translocator Protein TSPO

  2023cites this paper
• Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages

  2023cites this paper
• Distinct molecular profiles of skull bone marrow in health and neurological disorders

  2023cites this paper
• Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH–Wild-Type Glioblastoma

  2023influential citation
• Advances in the application of neuroinflammatory molecular imaging in brain malignancies

  2023cites this paper
• Hybrid PET/MRI in Cerebral Glioma: Current Status and Perspectives

  2023cites this paper
• Clinical Applications of TSPO PET for Glioma Imaging: Current Evidence and Future Perspective—A Systematic Review

  2023cites this paper
• A feasibility study for quantitative assessment of cerebrovascular malformations using flutriciclamide ([18F]GE-180) PET/MRI

  2023cites this paper
• High-Grade Glioma Radiation Therapy and Reirradiation Treatment Planning Using Translocator Protein Positron Emission Tomography With 18F-GE-180

  2023influential citation
• Molecular imaging of tumor-associated macrophages in cancer immunotherapy

  2022cites this paper
• PET Imaging in Neuro-Oncology: An Update and Overview of a Rapidly Growing Area

  2022cites this paper
• A Comparison of PET Tracers in Recurrent High-Grade Gliomas: A Systematic Review

  2022cites this paper
• TSPO PET signal using [18F]GE180 is associated with survival in recurrent gliomas

  2022cites this paper
• 18 kDa translocator protein positron emission tomography facilitates early and robust tumor detection in the immunocompetent SB28 glioblastoma mouse model

  2022cites this paper
• The Effect of the Classical TSPO Ligand PK 11195 on In Vitro Cobalt Chloride Model of Hypoxia-like Condition in Lung and Brain Cell Lines

  2022cites this paper
• PET radiotracers in glioma: a review of clinical indications and evidence

  2022cites this paper
• [64Cu]Cu-ATSM: an emerging theranostic agent for cancer and neuroinflammation

  2022cites this paper
• Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine

  2022influential citation
• In Vivo Quantitative Imaging of Glioma Heterogeneity Employing Positron Emission Tomography

  2022influential citation
• Investigational PET tracers in neuro-oncology-What's on the horizon? A report of the PET/RANO group.

  2022cites this paper
• Design of a Multi-Epitopes Based Chimeric Vaccine against Enterobacter cloacae Using Pan-Genome and Reverse Vaccinology Approaches

  2022cites this paper
• Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?

  2022cites this paper
• Impact of Partial Volume Correction on [18F]GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal Syndrome

  2022cites this paper
• Nuclear medicine and radiotherapy in the clinical management of glioblastoma patients

  2022cites this paper
• Essential Principles and Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging.

  2022cites this paper
• Longitudinal [18F]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse Model

  2022cites this paper
• Impact of TSPO Receptor Polymorphism on [18F]GE-180 Binding in Healthy Brain and Pseudo-Reference Regions of Neurooncological and Neurodegenerative Disorders

  2021cites this paper
• Pediatric Molecular Imaging

  2021cites this paper
• Proteome wide vaccine targets prioritization and designing of antigenic vaccine candidate to trigger the host immune response against the Mycoplasma genitalium infection.

  2021cites this paper
• Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group.

  2021cites this paper
• A Critical Review of PET Tracers Used for Brain Tumor Imaging.

  2021cites this paper
• Mapping of Translocator Protein (18 kDa) in Peripheral Sterile Inflammatory Disease and Cancer through PET Imaging.

  2021cites this paper
• Imaging of the glioma microenvironment by TSPO PET

  2021cites this paper
• Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas

  2021cites this paper
• A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma

  2021cites this paper
• Exploring Translocator Protein (TSPO) Medicinal Chemistry: An Approach for Targeting Radionuclides and Boron Atoms to Mitochondria.

  2021cites this paper
• MRI and PET of Brain Tumor Neuroinflammation in the Era of Immunotherapy, From the AJR Special Series on Inflammation.

  2021cites this paper
• Pan-vaccinomics approach towards a universal vaccine candidate against WHO priority pathogens to address growing global antibiotic resistance

  2021cites this paper
• Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases

  2021cites this paper
• Differential Spatial Distribution of TSPO or Amino Acid PET Signal and MRI Contrast Enhancement in Gliomas

  2021cites this paper
• Annotation of Potential Vaccine Targets and Design of a Multi-Epitope Subunit Vaccine against Yersinia pestis through Reverse Vaccinology and Validation through an Agent-Based Modeling Approach

  2021cites this paper
• The Effect of the Classical TSPO Ligand PK 11195 On in Vitro Cobalt Chloride Model of Hypoxia in Non-Neuronal and Brain Cell Lines

  2021cites this paper
• Multi-omics and 3D-imaging reveal bone heterogeneity and unique calvaria cells in neuroinflammation

  2021cites this paper
• In vivo monitoring of remnant undifferentiated neural cells following human induced pluripotent stem cell‐derived neural stem/progenitor cells transplantation

  2020cites this paper
• Membrane-embedded TSPO: an NMR view

  2020cites this paper
• The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma

  2020cites this paper
• Dual PET Imaging of an H3K27M-Mutant Glioma With 18F-GE-180 and 18F-FET PET.

  2020cites this paper
• Targeting Mitochondria in Tumor-Associated Macrophages using a Dendrimer Conjugated TSPO Ligand Stimulates Anti-Tumor Signaling in Glioblastoma.

  2020cites this paper
• Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance

  2020cites this paper
• Selective, high-contrast detection of syngeneic glioblastoma in vivo

  2020cites this paper
• In response to: Anatomy of 18F-GE180, a failed radioligand for the TSPO protein

  2020cites this paper
• Reliable quantification of 18F-GE-180 PET neuroinflammation studies using an individually scaled population-based input function or late tissue-to-blood ratio

  2020cites this paper
• Recent advances of PET imaging in clinical radiation oncology

  2020cites this paper
• Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors

  2020cites this paper
• Positron emission tomography to image cerebral neuroinflammation in ischaemic stroke: a pilot study

  2020cites this paper
• Anatomy of 18F-GE180, a failed radioligand for the TSPO protein

  2020cites this paper
• TSPO imaging-guided characterization of the immunosuppressive myeloid tumor microenvironment in patients with malignant glioma.

  2020cites this paper
• The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors

  2020influential citation
• Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells

  2020cites this paper
• In response to: The validity of 18F-GE180 as a TSPO imaging agent

  2019cites this paper
• Contribution of Different Positron Emission Tomography Tracers in Glioma Management: Focus on Glioblastoma

  2019cites this paper
• The yin and yang of imaging tumor associated macrophages with PET and MRI

  2019cites this paper
• The Molecular Effects of Ionizing Radiations on Brain Cells: Radiation Necrosis vs. Tumor Recurrence

  2019cites this paper
• Cigarette smoke, saliva, the translocator protein 18kDa (TSPO) and oral cancer.

  2019cites this paper
• Imaging-guided precision medicine in glioblastoma patients treated with immune checkpoint modulators: research trend and future directions in the field of imaging biomarkers and artificial intelligence

  2019cites this paper
• PET biomarkers and probes for treatment response assessment in glioblastoma: a work in progress

  2019cites this paper
• TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative 18F-GE-180 PET study

  2019influential citation
• Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism

  2019cites this paper
• Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter

  2019cites this paper
• The validity of 18F-GE180 as a TSPO imaging agent

  2019cites this paper
• Evaluation of the novel TSPO radiotracer 2-(7-butyl-2-(4-(2-([18F]fluoroethoxy)phenyl)-5-methylpyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide in a preclinical model of neuroinflammation.

  2018cites this paper
• Effects of genetic variants in the TSPO gene on protein structure and stability

  2018cites this paper
• TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing–remitting multiple sclerosis

  2018cites this paper
• PET imaging in glioma: techniques and current evidence

  2018cites this paper
• Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study

  2018cites this paper
• Synthesis of two novel [18F]fluorobenzene-containing radiotracers via spirocyclic iodonium ylides and positron emission tomography imaging of translocator protein (18 kDa) in ischemic brain.

  2018cites this paper
• Translocator Protein (TSPO) as a Potential Biomarker in Human Cancers

  2018cites this paper
• The Use of Translocator protein 18 kDa (Tspo) as a Biomarker in Various Human Cancers

  2018cites this paper
• Investigational PET tracers for high-grade gliomas.

  2018cites this paper
• Highlights of the 30th Annual Congress of the EANM, Vienna 2017: “Yes we can – make nuclear medicine great again”

  2018cites this paper
• Detection of Cerebrospinal Fluid Dissemination of Recurrent Glioblastoma Using TSPO-PET With 18F-GE-180.

  2018cites this paper
• Neuro-PET – ein Update

  2018cites this paper
• Neuroimaging in patients with high-grade gliomas.

  2018cites this paper
• Head-to-Head Comparison of 11C-PBR28 and 18F-GE180 for Quantification of the Translocator Protein in the Human Brain

  2018cites this paper